Tanabe Seiyaku Co., Ltd. - SWOT Analysis
| Publication Date | May 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 17 |
| ISBN Number | not applicable |
| Product Code | DAT05476 |
Summary
The Tanabe Seiyaku Co., Ltd.
- SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Tanabe Seiyaku (Tanabe) is primarily engaged in the research, development, manufacture and sale of pharmaceuticals, including ethical drugs, over-the-counter (OTC) drugs and diagnostics. Its pharmaceutical products include Remicade, Herbesser, Tanatril and Gastrom among others. The company is also engaged in the manufacture and sale of chemical products and food additives. The company primarily operates in Japan, the US and China. It is headquartered in Osaka, Japan and employs about 4,500 people. The company recorded revenues of JPY177,531 million (approximately $1,505.6 million) during the fiscal year ended March 2007, an increase of 3.5% over 2006. The operating profit of the company was JPY30,456 million (approximately $258.3 million) during fiscal year 2007, an increase of 10.5% over 2006. The net profit was JPY20,174 million (approximately $171.1 million) in fiscal year 2007, an increase of 30.4% over 2006. Note: The company has not declared the audited results for the fiscal year 2007 at the time of the publication of the profile.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Content
This product typically includes the following sections:
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- SWOT analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















